Numerous studies on colorectal cancer have highlighted the significance of tumor lymphocytic reaction and T-cell subpopulations as substantial prognostic biomarkers, even following adjustments for stage, lymph node count, and well-established prognostic indicators like BRAF mutation [168,169]. Here, BRAF is linked to neoplasm.